爱康临床研究 ICLR
$204.74 +$3.09 (+1.53%)
休市 · Nov 7, 9:50 pm ET · 最新盘后价 $204.74 0.00%
开盘$200.87
昨收$201.65
当日区间$200.54 – $208.26
成交量1.38M
市值$15.34B
市盈率（TTM）35.5
股息率–
财报
财报日平均波动±8.7%近16次财报
收涨次数9 / 1656% 的概率
最佳反应+17.0%
最差反应-21.0%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q3 | 27 Oct 2026 | After Market | ±11.1% | +17.04% | 超出定价预期 |
| 2026/Q2 | 29 Jul 2026 | After Market | ±13.3% | -7.10% | 符合区间 |
| 2026/Q1 | 23 Jun 2026 | After Market | ±10.6% | +10.86% | 超出定价预期 |
| 2025/Q4 | 27 May 2026 | After Market | ±14.3% | +15.49% | 超出定价预期 |
| 2025/Q3 | 22 Oct 2025 | After Market | ±13.8% | -6.54% | 符合区间 |
| 2025/Q2 | 23 Jul 2025 | After Market | ±13.4% | +16.15% | 超出定价预期 |
| 2025/Q1 | 30 Apr 2025 | After Market | ±15.2% | -4.11% | 符合区间 |
| 2024/Q4 | 19 Feb 2025 | After Market | ±8.5% | +5.50% | 符合区间 |
| 2024/Q3 | 23 Oct 2024 | After Market | ±10.6% | -21.03% | 超出定价预期 |
| 2024/Q2 | 24 Jul 2024 | After Market | ±9.2% | -5.63% | 符合区间 |
| 2024/Q1 | 24 Apr 2024 | After Market | ±8.4% | -3.02% | 符合区间 |
| 2023/Q4 | 21 Feb 2024 | After Market | ±8.9% | +10.07% | 超出定价预期 |
| 2023/Q3 | 25 Oct 2023 | After Market | ±11.0% | +6.78% | 符合区间 |
| 2023/Q2 | 26 Jul 2023 | After Market | ±9.1% | -4.53% | 符合区间 |
| 2022/Q4 | 22 Feb 2023 | After Market | – | +0.64% | – |
| 2022/Q3 | 2 Nov 2022 | After Market | ±8.7% | +4.58% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$2.06B+1.2% YoY
营业利润$194.21M-30.8% YoY
净利润$72.58M-64.3% YoY
摊薄每股收益$0.94-63.3% YoY
自由现金流$238.85M+109.7% YoY
经营现金流$281.27M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率23.9%
营业利润率10.1%
净利率0.5%
净资产收益率0.4%
资产收益率0.3%
投入资本回报率1.2%
流动比率0.95
负债/资产比率42.8%
现金及投资$928.39M
总负债$3.49B
净现金（净负债）-$2.56B
自由现金流/营收10.7%
暂无评论——快来第一个聊聊 ICLR。
登录后参与讨论。